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Data Sources

Implications for Practice

Databases were searched using the keywords:
magnesium, and type 2 diabetes mellitus.

Magnesium plays such
a vital role in cellular
health that the reviewed
studies suggested keeping
serum magnesium
levels on the high side
of normal. Magnesium
supplementation is
relatively safe, affordable,
and vital for many
functions in the body;
therefore, oral magnesium
supplementation is
recommended.

Limitations
Magnesium status is difficult to determine because only
1% of the body’s magnesium is found in the blood, 50%
is found in the bones, and the rest resides in cells of
tissues and organs (NIH, 2009).

Results

Purpose
To examine the relationship of magnesium levels related
to insulin resistance and type 2 diabetes mellitus.

Background and Significance
Diabetes is a metabolic disease in which the body does
not produce or correctly use insulin to maintain proper
levels of glucose in the blood resulting in serious health
consequences. Diabetes is a major factor in
• coronary heart disease
• stroke as well as blindness
• kidney failure
• non-traumatic amputations due to disruption of the
microvascular system (Schulze & Hu, 2005).
The Center for Disease Control reported in 2007:
• 23.6 million people in the United States (7.8% of the
population) have diabetes
• 17.9 million diagnosed
• 5.7 million people undiagnosed
Every year marks a large increase in the number of
people diagnosed with diabetes.
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Seven research articles were reviewed which
investigated the relationship between serum magnesium
levels and type 2 diabetes mellitus. Supplemental
magnesium did not clearly decrease the need for
medication for glucose control, although the length of
the studies may have been too short to be conclusive.
All seven articles suggested that magnesium
supplementation did reduce insulin resistance.

Conclusions
Recent studies suggest that oral magnesium
supplementation is inexpensive, safe, and well
tolerated. Magnesium supplementation has been
suggested to decrease insulin resistance and delay the
onset of type 2 diabetes mellitus.
The current RDA for magnesium, adjusted to age and
gender, seems adequate; however, these groups are
subseptable to hypomagnesaemia:
• women
• the elderly
• those living in soft water areas
• those at increased risk for magnesium loss
• those with a magnesium binding defect
The beneficial effects directly attributable to magnesium
supplementation in some studies, suggest the need for
further research.
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Research data are
inadequate at this time to prove that oral
magnesium intake decreases the need for
hypoglycemic agents. Until conclusive data
is obtained, maintaining a high average serum
magnesium level has few side effects and any
potential delay in the onset of diabetes is beneficial
for helping to prevent the complications of diabetes.

